Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Blood|May 2, 2013
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)Verena I Gaidzik, Richard F Schlenk, Peter Paschka, et al.
Hemasphere|August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 TrialHartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative GroupStefan Gröschel, Richard F Schlenk, Jan Engelmann, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Leukemia|May 4, 2018
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trialPeter Paschka, Richard F Schlenk, Daniela Weber, et al.
Blood|December 28, 2020
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trialSilke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Pageof 4